The researchers focused on a subset of All those individuals — about one,seven hundred — who both had diabetes, have been overweight or had weight problems, and when compared results following 36 months in individuals that were being prescribed semaglutide to individuals who weren’t. Semaglutide will be the component in copyright and Wegovy.